Relation of ischemia-modified albumin levels and left ventricular systolic function in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention

Clinica Chimica Acta

Volumn 388, Issue 1-2, 2008, Pages 196-199

  Dominguez Rodriguez, Alberto ^a   Abreu Gonzalez, Pedro ^b   Garcia Gonzalez, Martín J ^a   Samimi Fard, Sima ^a   Kaski, Juan Carlos ^c  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Coronary care unit; Heart failure; Ischemia modified albumin; Left ventricular ejection fraction; Percutaneous coronary intervention; ST segment elevation myocardial infarction

Indexed keywords

ALBUMIN;

AGED; ARTICLE; COLORIMETRY; CONTROLLED STUDY; CORONARY CARE UNIT; CORRELATION ANALYSIS; FEMALE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION; STATISTICAL SIGNIFICANCE;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; HEART FAILURE; HUMANS; ISCHEMIA; MALE; MYOCARDIAL INFARCTION; SERUM ALBUMIN; STENTS; VENTRICULAR FUNCTION, LEFT;

EID: 37249016627     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.10.030     Document Type: Article

References (18)

1. Ide T., Tsutsui H., Kinugawa S., et al. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Cir Res 85 (1999) 357-363
2. Nakamura K., Kusano K., Nakamura Y., et al. Carvedilol decreases elevated oxidative stress in human failing myocardium. Circulation 105 (2002) 2867-2871
3. Josephson R.A., Silverman H.S., Lakatta E.G., Stern M.D., and Zweier J.L. Study of the mechanisms of hydrogen peroxide and hydroxyl free radical induced cellular injury and calcium overload in cardiac myocytes. J Biol Chem 266 (1991) 2354-2361
4. +2 binding amino-acid residues of the N-terminus of human albumin: an insight into the mechanism of a new assay for myocardial ischemia. Eur J of Biochem 268 (2001) 42-47
5. Sinha M.K., Gaze D.C., Tippins J.R., Collinson P.O., and Kaski J.C. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 107 (2003) 2403-2405
6. Quiles J., Roy D., Gaze D., et al. Ischemia modified albumin (IMA) levels following elective angioplasty are related to duration of balloon induced myocardial ischemia. Am J Cardiol 92 (2003) 322-324
7. Bar-Or D., Lau E., and Winkler J.V. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia - a preliminary report. J Emerg Med 19 (2000) 311-315
8. Killip T., and Kimball J.T. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 20 (1967) 457-464
9. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-367
10. Yamamoto K., Nishimura R.A., Chaliki H.P., Appleton C.P., Holmes D.R., and Redfield M.M. Determination of left ventricular filling pressure by Doppler echocardiography in patients with coronary artery disease: critical role of left ventricular systolic function. J Am Coll Cardiol 30 (1997) 1819-1826
11. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
12. Dusek J., St'asek J., Tichy M., et al. Prognostic significance of ischemia modified albumin after percutaneous coronary intervention. Clin Chim Acta 367 (2006) 77-80
13. Bar-Or D., Winkler J.V., VanBenthysen K., Harris L., Lau E., and Hetzel F.W. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am Heart J 141 (2001) 985-991
14. Dominguez-Rodriguez A., Abreu-Gonzalez P., de la Rosa A., Vargas M., Ferrer J., and Garcia M. Role of endogenous interleukin-10 production and lipid peroxidation in patients with acute myocardial infarction treated with primary percutaneous transluminal coronary angioplasty, interleukin-10 and primary angioplasty. Int J Cardiol 99 (2005) 77-81
15. Sawyer D.B., Siwik D.A., Xiao L., Pimentel D.R., Singh K., and Colucci W.S. Role of oxidative stress in myocardial hypertrophy and failure. J Mol Cell Cardiol 34 (2002) 379-388
16. Roy D., Quiles J., Gaze D.C., Collinson P., Kaski J.C., and Baxter G.F. Role of reactive oxygen species on the formation of the novel diagnostic marker ischemia modified albumin. Heart 92 (2006) 113-114
17. Halliwell B. Albumin: an important extracellular antioxidant?. Biochem Pharmacol 37 (1988) 569-571
18. Christenson R.H., Duh S.H., Sanhai W.R., et al. Characteristics of an albumin cobalt binding test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 47 (2001) 464-470